Table 1
Tiziana Life Sciences Announces Additional Clinical Improvements Among Multiple Sclerosis Patients in its Expanded Access Program
22 avr. 2024 07h00 HE | Tiziana Life Sciences Ltd.
70% of Patients in the Expanded Access Program (EAP) Have Seen Measurable Clinical Improvement in Their Fatigue After Six Months of Follow-upAll Patients Have Either Stabilized or Improved on Nasal...
RM Primary Logo - Humble.png
Revolution Medicines Announces Publications on the Discovery and Preclinical Profile of Representative of a New Class of RAS(ON) Multi-Selective Inhibitors Designed to Block Full Spectrum of Oncogenic RAS(ON) Proteins
08 avr. 2024 11h36 HE | Revolution Medicines, Inc.
Two original papers in Nature highlight the discovery and translational implications of RMC-7977, a RAS(ON) multi-selective tri-complex inhibitor that exhibits unprecedented anti-tumor activity in...
Full Logo - OKYO .jpg
OKYO Pharma Announces Upcoming Presentation of OK-101 Phase 2 Data for Dry Eye Disease at Eyecelerator 2024, a Partner Meeting of the American Society for Cataract and Refractive Surgery
02 avr. 2024 07h00 HE | OKYO Pharma LTD
LONDON and NEW YORK, April 02, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of...
Foundation for Opioi
Foundation for Opioid Response Efforts (FORE) Announces $1.4 Million Grant to Equal Justice Works to Launch National Legal Fellowship Program
21 mars 2024 10h30 HE | Foundation for Opioid Response Efforts
New York, March 21, 2024 (GLOBE NEWSWIRE) -- The Foundation for Opioid Response Efforts (FORE) today announced it is awarding a grant of $1,361,005 over 30 months to Equal Justice Works to launch a...
Full Logo - OKYO .jpg
OKYO Pharma to Release New and Comprehensive Data from Phase 2 Dry Eye Disease Trial and Host Key Opinion Leader Event
20 mars 2024 07h00 HE | OKYO Pharma LTD
LONDON and NEW YORK, March 20, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of...
Complete Clarity Solicitors TA Family Lawyers Glasgow Logo.png
Family Lawyers Glasgow Unveils Enhanced Website to Elevate Client Experience GLASGOW, UK, March 12, 2024 (GLOBE NEWSWIRE) -- Family Lawyers Glasgow, a leading provider of expert family law advice in Scotland, is proud to announce the launch of its newly redesigned website....
Updated Logo 2023 (3).png
Legal Soft Enhances Virtual Legal Staffing Services with New Law Firm Accounting Role
07 mars 2024 14h09 HE | Legal Soft
LOS ANGELES, March 07, 2024 (GLOBE NEWSWIRE) -- Legal Soft, a leading provider of virtual legal staffing solutions, is excited to announce the expansion of its service offerings with the...
orea.png
The Ontario Real Estate Association Announces New 2024 President and Board of Directors
06 mars 2024 10h00 HE | Ontario Real Estate Association
TORONTO, March 06, 2024 (GLOBE NEWSWIRE) -- The Ontario Real Estate Association (OREA) has announced that Oakville-based real estate broker, Rick Kedzior, has assumed the role of President of OREA....
SFWJLogo.png
SFWJ DBA MedCana Names Seasoned Agri-Tech Leader Paula Restrepo as Sales Director for Subsidiary Eko20 S.A.S.
28 févr. 2024 08h45 HE | Software Effective Solutions Corp. (d/b/a MedCana)
AUSTIN, Texas, Feb. 28, 2024 (GLOBE NEWSWIRE) -- via IBN – SFWJ dba MedCana announces that Eko2o S.A.S., a majority controlled subsidiary of MedCana/SFWJ in Colombia and a leading provider of...
Updated Logo 2023 (3).png
Legal Soft Announces Clio Partnership to Elevate Legal Practice Efficiency
08 févr. 2024 13h00 HE | Legal Soft
LOS ANGELES, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Legal Soft, a leading virtual legal staffing company has partnered with Clio, the world’s most robust legal technology platform. Legal Soft is at the...